In a step to­ward short­er tu­ber­cu­lo­sis treat­ment, GSK re­ports pos­i­tive mid-stage da­ta for an­tibi­ot­ic

GSK says an ex­per­i­men­tal tu­ber­cu­lo­sis drug has de­liv­ered pos­i­tive re­sults in a Phase IIa, paving the way for com­bi­na­tion reg­i­mens that can be test­ed in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER